Loomis, Sayles & Company’s Artivion AORT Stock Holding History
Bought
Maintained
Sold
Other funds holding AORT
NAMI
JIC
OAM
PA
CCA
Loomis, Sayles & Company's AORT Position: Q2 2026 in Review
Loomis, Sayles & Company sold out of Artivion (AORT) in Q2 2026, closing a stake of 980,439 shares — an estimated $35.9M sold.
Loomis, Sayles & Company first reported a position in AORT in Q3 2019 and held it in 7 quarters. The position peaked at $38.3M in Q4 2025. 206 funds tracked by Wall St. Rank hold AORT as of Q2 2026.
- Loomis, Sayles & Company reported no remaining Artivion position as of Q2 2026 after selling out during the quarter.
- Loomis, Sayles & Company sold 980,439 Artivion shares in Q2 2026, an estimated $35.9M.
- Loomis, Sayles & Company first reported a position in Artivion in Q3 2019 and held it in 7 quarters.
- Loomis, Sayles & Company's Artivion position peaked at $38.3M in Q4 2025.
- 206 funds tracked by Wall St. Rank held Artivion as of Q2 2026.
Based on Loomis, Sayles & Company's 13F filing for Q2 2026, filed 14 Aug 2026.